Steven Gilman

Steven Gilman

Directeur/Membre du Conseil chez SCYNEXIS, INC.

Fortune : 166 250 $ au 31/05/2026

73 ans
Health Technology
Commercial Services
Consumer Services

Profil

Steven C.
Gilman
is an Independent Director at SCYNEXIS, Inc. since 2015.
Holds Director positions at the Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Former roles include Vice Chairman at ContraFect Corp.
from 2019 to 2023; Chairman & Chief Executive Officer at ActivBiotics, Inc. from 2006 to 2007; Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018; Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2026; Independent Director at Vericel Corp.
from 2015 to 2025; Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC from 2010 to 2015; Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc. from 2000 to 2004; Executive Director at Inhibikase Therapeutics, Inc. from 2014 to 2016; Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc.; Group Director-Global Research & Development at Pfizer (St. Louis); Director at Massachusetts Biotechnology Council, Nextcea, Inc., and other firms; Scientist at Wyeth LLC; Principal at Connecticut College and Temple University School of Medicine; General Manager at Inflammation Research Association, Inc. Education includes undergraduate studies at Miami University and graduate and doctorate degrees from The Pennsylvania State University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/06/2025 152 830 ( 0,06 % ) 155 887 $ 31/05/2026
01/04/2026 14 700 ( 0,02 % ) 10 364 $ 31/05/2026

Postes actifs de Steven Gilman

SociétésPosteDébut
SCYNEXIS, INC. Directeur/Membre du Conseil 25/02/2015
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 07/07/2009
Directeur/Membre du Conseil -

Anciens postes connus de Steven Gilman

SociétésPosteFin
AKEBIA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/04/2026
VERICEL CORPORATION Directeur/Membre du Conseil 30/04/2025
CONTRAFECT CORPORATION Directeur Général 02/04/2019
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Steven Gilman

Formation de Steven Gilman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Steven Gilman
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇